Currently out of the existing stock ratings of Colin Bristow, 48 are a BUY (60%), 32 are a HOLD (40%).

Colin Bristow

Work Performance Price Targets & Ratings Chart

Analyst Colin Bristow works at UBS with a stock forecast success ratio of 63.06% fulfilled within 168.05 days on average. Previously, Colin Bristow worked at BAML.

Colin Bristow’s has documented 189 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BTAI, BioXcel Therapeutics at 21-Feb-2024.

Wall Street Analyst Colin Bristow

Analyst best performing recommendations are on IMVT (IMMUNOVANT ).
The best stock recommendation documented was for IMVT (IMMUNOVANT ) at 9/26/2022. The price target of $5 was fulfilled within 3 days with a profit of $0.48 (10.62%) receiving and performance score of 35.4.

Average potential price target upside

ALXN Alexion Pharmaceuticals AMGN Amgen BIIB Biogen BTAI BioXcel Therapeutics GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck mpany MTEM Molecular Templates OMER Omeros PFE Pfizer PTCT PTC Therapeutics SRPT Sarepta Therapeutics VRTX Vertex Pharmaceuticals ABBV AbbVie CCCC C4 Therapeutics  BMY Bristol-Myers Squibb Company RCKT Rocket Pharmaceuticals ALXO Alx Oncology Holdings  IMVT Immunovant  REGN Regeneron Pharmaceuticals ABOS Acumen Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

205

$22.5 (12.33%)

2 years 9 months 19 days ago

3/5 (60%)

$35.09 (20.65%)

938

Hold

173

$-9.5 (-5.21%)

156

2 years 9 months 21 days ago

14/24 (58.33%)

$2.73 (1.60%)

682

Hold

190

$7.5 (4.11%)

147

3 years 20 days ago

9/11 (81.82%)

$34.41 (22.12%)

350

Hold

166

$-16.5 (-9.04%)

175

3 years 20 days ago

27/27 (100%)

$10.41 (6.69%)

830

Buy

155

3 years 1 months 17 days ago

7/7 (100%)

$36.79 (31.12%)

395

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Colin Bristow is most bullish on?

Potential upside of $28.82 has been obtained for AMGN (AMGEN)

Which stock is Colin Bristow is most reserved on?

Potential downside of -$0.76 has been obtained for PFE (PFIZER)

What Year was the first public recommendation made by Colin Bristow?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?